Effects of race on lipid-lowering management in hospitalized patients with coronary heart disease

被引:4
|
作者
Dressler, DD
Jacobson, TA
机构
[1] Emory Univ, Sch Med, Dept Med, Div Gen Med, Atlanta, GA 30303 USA
[2] Hosp Med Unit, Atlanta, GA USA
[3] Off Hlth Promot & Dis Prevent, Grady Hlth Syst, Atlanta, GA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 09期
关键词
D O I
10.1016/j.amjcard.2004.01.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to determine the association between patient characteristics, specifically race, and the appropriate management of lipid-reducing therapy in patients with coronary heart disease (CHD) discharged from the hospital. Two hundred fifty-eight consecutive patients with diagnoses suggestive of CHD were identified in a large, inner-city university teaching hospital serving a predominantly indigent African American population. The outcome measure, suboptimal lipid management, evaluated the intensification of lipid-reducing therapy when indicated using the National Cholesterol Education Program guidelines for the low-density lipoprotein cholesterol goal. The overall rate of suboptimal lipid management was 48%. Black patients with CHD were significantly more likely to have suboptimal lipid management than nonblack patients by the time of hospital discharge (52.3% vs 16.7%, p = 0.021). The disparity in the clinical management of black patients with CHD may help explain the differential in health outcomes seen between black and white patients. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:1167 / 1170
页数:4
相关论文
共 50 条
  • [41] EFFECTS OF INTENSIVE LIPID LOWERING WITH ATORVASTATIN ON PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH CORONARY HEART DISEASE
    Larsen, M. Lytken
    Holme, I.
    Tikkanen, M.
    Fayyad, R.
    Laskey, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 175 - 175
  • [42] Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany
    Wassmuth, Stephan
    Rohe, Katharina
    Noack, Frank
    Noutsias, Michel
    Treede, Hendrik
    Schlitt, Axel
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 477 - 483
  • [43] Comparison of characteristics of patients with coronary heart disease receiving lipid-lowering therapy versus those not receiving such therapy
    Kopjar, B
    Sales, AEB
    Piñeros, SL
    Sun, HL
    Li, YF
    Hedeen, AN
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (11): : 1352 - 1354
  • [44] Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study
    Cesari, M
    Maiolino, G
    Colonna, S
    Zanchetta, M
    Pedon, L
    Maiolino, P
    Pessina, AC
    Rossi, GP
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (04) : 484 - 490
  • [45] INTENSITY OF LIPID-LOWERING THERAPY, ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE
    Mazhar, F.
    Hjemdahl, P.
    Clase, C. M.
    Johnel, K.
    Jernberg, T.
    Carrero, J. J.
    ATHEROSCLEROSIS, 2022, 355 : E301 - E301
  • [46] Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease
    Mazhar, Faizan
    Hjemdahl, Paul
    Clase, Catherine M.
    Johnell, Kristina
    Jernberg, Tomas
    Sjolander, Arvid
    Carrero, Juan Jesus
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (14):
  • [47] The effects of lipid-lowering therapy on graft patency in coronary bypass surgery patients
    Sungun, Mutasim
    Hulusi, Melih
    Ulusoy, Rifat Eralp
    Keskin, Ozcan
    Pocan, Sibel
    Inan, Kaan
    Yilmaz, Ahmet Turan
    HEART SURGERY FORUM, 2006, 9 (03): : E626 - E629
  • [48] Non-lipid lowering effects of statin medication in patients with coronary heart disease
    Bickel, C
    Rupprecht, HJ
    Blankenberg, S
    Hafner, G
    Rippin, G
    Meyer, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 256A - 256A
  • [49] EFFECTS OF LIPID-LOWERING DIETS ON PATIENTS WITH HYPERLIPOPROTEINEMIA
    GUSTAFSSON, IB
    VESSBY, B
    BOBERG, J
    KARLSTROM, B
    LITHELL, H
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1982, 80 (05) : 426 - 432
  • [50] Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the get with the guidelines database)
    Albert, Nancy M.
    Birtcher, Kimberly K.
    Cannon, Christopher P.
    Goff, David C., Jr.
    Mulgund, Jyotsna
    Liang, Li
    Fonarow, Gregg C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (09): : 1242 - 1246